426 related articles for article (PubMed ID: 24140476)
1. Genetic variations in IL6 and IL12B decreasing the risk for psoriasis.
Boca AN; Talamonti M; Galluzzo M; Botti E; Vesa SC; Chimenti S; Buzoianu AD; Costanzo A
Immunol Lett; 2013; 156(1-2):127-31. PubMed ID: 24140476
[TBL] [Abstract][Full Text] [Related]
2. Genetic variation at IL12B, IL23R and IL23A is associated with psoriasis severity, psoriatic arthritis and type 2 diabetes mellitus.
Eirís N; González-Lara L; Santos-Juanes J; Queiro R; Coto E; Coto-Segura P
J Dermatol Sci; 2014 Sep; 75(3):167-72. PubMed ID: 24957500
[TBL] [Abstract][Full Text] [Related]
3. IL12B (p40) Gene Polymorphisms Contribute to Ustekinumab Response Prediction in Psoriasis.
Galluzzo M; Boca AN; Botti E; Potenza C; Malara G; Malagoli P; Vesa S; Chimenti S; Buzoianu AD; Talamonti M; Costanzo A
Dermatology; 2016; 232(2):230-6. PubMed ID: 26678060
[TBL] [Abstract][Full Text] [Related]
4. Association of IL12B risk haplotype and lack of interaction with HLA-Cw6 among the psoriasis patients in India.
Chandra A; Senapati S; Ghosh S; Chatterjee G; Chatterjee R
J Hum Genet; 2017 Mar; 62(3):389-395. PubMed ID: 27829679
[TBL] [Abstract][Full Text] [Related]
5. Resequencing of the IL12B gene in psoriasis patients with the rs6887695/rs3212227 risk genotypes.
Eiris N; Santos-Juanes J; Coto-Segura P; Gómez J; Alvarez V; Morales B; Queiro R; Díaz M; Corao AI; López-Corte K; Coto E
Cytokine; 2012 Oct; 60(1):27-9. PubMed ID: 22739501
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms of the IL12B and IL23R genes are associated with psoriasis.
Nair RP; Ruether A; Stuart PE; Jenisch S; Tejasvi T; Hiremagalore R; Schreiber S; Kabelitz D; Lim HW; Voorhees JJ; Christophers E; Elder JT; Weichenthal M
J Invest Dermatol; 2008 Jul; 128(7):1653-61. PubMed ID: 18219280
[TBL] [Abstract][Full Text] [Related]
7. Association between psoriasis and polymorphisms in the TNF, IL12B, and IL23R genes in Spanish patients.
Cabaleiro T; Román M; Gallo E; Ochoa D; Tudelilla F; Talegón M; Prieto-Pérez R; García-Díez A; Daudén E; Abad-Santos F
Eur J Dermatol; 2013; 23(5):640-5. PubMed ID: 24135300
[TBL] [Abstract][Full Text] [Related]
8. IL12B, IL23A, IL23R and HLA-C*06 genetic variants in psoriasis susceptibility and response to treatment.
Bojko A; Ostasz R; Białecka M; Klimowicz A; Malinowski D; Budawski R; Bojko P; Droździk M; Kurzawski M
Hum Immunol; 2018 Apr; 79(4):213-217. PubMed ID: 29454820
[TBL] [Abstract][Full Text] [Related]
9. Investigation of association of the IL12B and IL23R genes with psoriatic arthritis.
Filer C; Ho P; Smith RL; Griffiths C; Young HS; Worthington J; Bruce IN; Barton A
Arthritis Rheum; 2008 Dec; 58(12):3705-9. PubMed ID: 19035472
[TBL] [Abstract][Full Text] [Related]
10. IL12B and IL23R gene SNPs in Japanese psoriasis.
Oka A; Mabuchi T; Ikeda S; Terui T; Haida Y; Ozawa A; Yatsu K; Kulski JK; Inoko H
Immunogenetics; 2013 Nov; 65(11):823-8. PubMed ID: 23955419
[TBL] [Abstract][Full Text] [Related]
11. Exploring ankylosing spondylitis-associated ERAP1, IL23R and IL12B gene polymorphisms in subphenotypes of psoriatic arthritis.
Jadon D; Tillett W; Wallis D; Cavill C; Bowes J; Waldron N; Dixon A; Sengupta R; Barton A; Korendowych E; McHugh NJ
Rheumatology (Oxford); 2013 Feb; 52(2):261-6. PubMed ID: 23093722
[TBL] [Abstract][Full Text] [Related]
12. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes.
Cargill M; Schrodi SJ; Chang M; Garcia VE; Brandon R; Callis KP; Matsunami N; Ardlie KG; Civello D; Catanese JJ; Leong DU; Panko JM; McAllister LB; Hansen CB; Papenfuss J; Prescott SM; White TJ; Leppert MF; Krueger GG; Begovich AB
Am J Hum Genet; 2007 Feb; 80(2):273-90. PubMed ID: 17236132
[TBL] [Abstract][Full Text] [Related]
13. TNFAIP3 and IL12B gene polymorphisms associated with psoriasis vulgaris in an Egyptian cohort.
Haase O; Mosaad H; Eldarouti MA; Elramly AZ; Samir N; Abdelhady MM; Samir M; El-Gharib I; Salah S; El-Shennawy FA; Mosaad Y; Elwan N; Salem H; Abdelgaber S; Recke A; Möller S; Zillikens D; Ibrahim S
J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1297-301. PubMed ID: 25406098
[TBL] [Abstract][Full Text] [Related]
14. The relationship between tumour necrosis factor (TNF)-α promoter and IL12B/IL-23R genes polymorphisms and the efficacy of anti-TNF-α therapy in psoriasis: a case-control study.
Gallo E; Cabaleiro T; Román M; Solano-López G; Abad-Santos F; García-Díez A; Daudén E
Br J Dermatol; 2013 Oct; 169(4):819-29. PubMed ID: 23662788
[TBL] [Abstract][Full Text] [Related]
15. IL12B SNPs and copy number variation in IL23R gene associated with susceptibility to leprosy.
Ali S; Srivastava AK; Chopra R; Aggarwal S; Garg VK; Bhattacharya SN; Bamezai RN
J Med Genet; 2013 Jan; 50(1):34-42. PubMed ID: 23240095
[TBL] [Abstract][Full Text] [Related]
16. Analysis of IL12B gene variants in inflammatory bowel disease.
Glas J; Seiderer J; Wagner J; Olszak T; Fries C; Tillack C; Friedrich M; Beigel F; Stallhofer J; Steib C; Wetzke M; Göke B; Ochsenkühn T; Diegelmann J; Czamara D; Brand S
PLoS One; 2012; 7(3):e34349. PubMed ID: 22479607
[TBL] [Abstract][Full Text] [Related]
17. Genetic variants of the IL-23R pathway: association with psoriatic arthritis and psoriasis vulgaris, but no specific risk factor for arthritis.
Hüffmeier U; Lascorz J; Böhm B; Lohmann J; Wendler J; Mössner R; Reich K; Traupe H; Kurrat W; Burkhardt H; Reis A
J Invest Dermatol; 2009 Feb; 129(2):355-8. PubMed ID: 18800148
[TBL] [Abstract][Full Text] [Related]
18. IL23R and IL12B polymorphisms in Spanish IBD patients: no evidence of interaction.
Márquez A; Mendoza JL; Taxonera C; Díaz-Rubio M; De La Concha EG; Urcelay E; Martínez A
Inflamm Bowel Dis; 2008 Sep; 14(9):1192-6. PubMed ID: 18383521
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis of IL12B polymorphisms (rs3212227, rs6887695) with psoriasis and psoriatic arthritis.
Zhu KJ; Zhu CY; Shi G; Fan YM
Rheumatol Int; 2013 Jul; 33(7):1785-90. PubMed ID: 23297015
[TBL] [Abstract][Full Text] [Related]
20. An interleukin 12 B single nucleotide polymorphism increases IL-12p40 production and is associated with increased disease susceptibility in patients with relapsing-remitting multiple sclerosis.
Javan MR; Shahraki S; Safa A; Zamani MR; Salmaninejad A; Aslani S
Neurol Res; 2017 May; 39(5):435-441. PubMed ID: 28276258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
